EUVIMEDEUVIMED entdecken
Crossref

Development of antisense peptide-peptide nucleic acids against fluoroquinolone-resistant Escherichia coli

Se Kye Kim, Jun Bong Lee, Hyung Tae Lee, Dalmuri Han, Jang Won Yoon iD

Journal of Antimicrobial Chemotherapy · 2023

DOI: 10.1093/jac/dkad203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2023. Verfasst von Se Kye Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine & Institute of Veterinary Science, Kangwon National University, Chuncheon, Gangwon 24341, Republic of Korea. Hauptthemen laut MEDLINE: Fluoroquinolones, Peptide Nucleic Acids. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Animal and Plant Quarantine Agency, Ministry of Agriculture, Food, and Rural Affairs, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fluoroquinolones (FQs) are potent and broad-spectrum antibiotics commonly used to treat MDR bacterial infections, but bacterial resistance to FQs has emerged and spread rapidly around the world. The mechanisms for FQ resistance have been revealed, including one or more mutations in FQ target genes such as DNA gyrase (gyrA) and topoisomerase IV (parC). Because therapeutic treatments for FQ-resistant bacterial infections are limited, it is necessary to develop novel antibiotic alternatives to minimize or inhibit FQ-resistant bacteria.

Objectives

To examine the bactericidal effect of antisense peptide-peptide nucleic acids (P-PNAs) that can block the expression of DNA gyrase or topoisomerase IV in FQ-resistant Escherichia coli (FRE).

Methods

A set of antisense P-PNA conjugates with a bacterial penetration peptide were designed to inhibit the expression of gyrA and parC and were evaluated for their antibacterial activities.

Results

Antisense P-PNAs, ASP-gyrA1 and ASP-parC1, targeting the translational initiation sites of their respective target genes significantly inhibited the growth of the FRE isolates. In addition, ASP-gyrA3 and ASP-parC2, which bind to the FRE-specific coding sequence within the gyrA and parC structural genes, respectively, showed selective bactericidal effects against FRE isolates.

Conclusions

Our results demonstrate the potential of targeted antisense P-PNAs as antibiotic alternatives against FQ-resistance bacteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluoroquinolonesPeptide Nucleic AcidsEscherichia coliDNA GyraseDNA Topoisomerase IVAnti-Bacterial AgentsBacteriaMutationMicrobial Sensitivity TestsDrug Resistance, Bacterial

Substanzen

FluoroquinolonesPeptide Nucleic AcidsDNA GyraseDNA Topoisomerase IVAnti-Bacterial Agents

Autor:innen und Institutionen

  • College of Veterinary Medicine & Institute of Veterinary Science, Kangwon National University, Chuncheon, Gangwon 24341, Republic of Korea.

ORCID-Profile: Jang Won Yoon

Förderung

  • Animal and Plant Quarantine Agency
  • Ministry of Agriculture, Food, and Rural Affairs, Republic of Korea

Zitieren

APA

Kim, S. K., Lee, J. B., Lee, H. T., Han, D., & Yoon, J. W. (2023). Development of antisense peptide-peptide nucleic acids against fluoroquinolone-resistant Escherichia coli. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkad203

Vancouver

Kim SK, Lee JB, Lee HT, Han D, Yoon JW. Development of antisense peptide-peptide nucleic acids against fluoroquinolone-resistant Escherichia coli. Journal of Antimicrobial Chemotherapy. 2023. doi:10.1093/jac/dkad203

BibTeX
@article{Kim2023,
  author = {Kim, Se Kye and Lee, Jun Bong and Lee, Hyung Tae and Han, Dalmuri and Yoon, Jang Won},
  title = {Development of antisense peptide-peptide nucleic acids against fluoroquinolone-resistant Escherichia coli},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2023},
  doi = {10.1093/jac/dkad203}
}
Kostenlos starten →